MEGIN Spotlights

In this MEGIN Spotlight, we welcome Dr. Christina Zhao, Director of the Lab for Early Auditory Perception (LEAP) within the Institute for Learning and Brain Sciences (I-LABS), Washington.

Dr. Zhao discusses her research into early learning and brain development, with a focus on how infants' brains process speech and music and how musical experiences can shape early development.

She also shares insights into the use of infant MEG within I-LABS, translating neuroscience research into educational practice, and the future directions of research supported by her new professorship.

In this episode:

• Introduction to Dr. Christina Zhao and ILABS
• The mission and focus of ILABS and LEAP
• Dr. Zhao's journey into auditory neuroscience
• Using MEG to study infant brain responses
• Music's role in shaping infant speech and language
• Translating research into educational and community impact
• The significance of the Paros Endowed Professorship and future research

To learn more:

Read the paper "Infant brain imaging using magnetoencephalography: Challenges, solutions, and best practices:" Human Brain Mapping | Neuroimaging Journal | Wiley Online Library.

Watch the accompanying video featuring how to test infants in the MEG: Infant brain imaging using magnetoencephalography: Challenges, solutions, and best practices

Institute for Learning and Brain Sciences (I-LABS): https://ilabs.uw.edu

The Lab for Early Auditory Perception (LEAP): https://sites.uw.edu/babyleap/

Don't forget to like and subscribe for more conversations at the forefront of brain science.

MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice. Consult your caregiver for medical advice.

TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

In this episode of the MEGIN Spotlights, we explore the rapidly evolving world of consumer brain health with MYndspan - a pioneering company making advanced brain insights more accessible than ever. Joined by co-founder & CEO Caitlin Baltzer and Chief Scientific Officer Dr. Benjamin Dunkley, we dive into how MEG (magnetoencephalography) technology is moving beyond hospitals and research labs into consumer health insights.

🔍In this episode, we cover:

• Why consumer health data is reshaping the future of healthcare
• How MYndspan uses non-invasive brain scans to deliver actionable insights
• The concept of "brain age" and what it reveals about your cognitive health
• Real-world case studies - from athletes to high-performance individuals
• The power of combining brain data with lifestyle factors like sleep, nutrition, and stress
• How MEG is unlocking earlier detection of functional brain changes, before symptoms appear

💡 With demand for proactive, personalized health insights on the rise, MYndspan is helping bridge the gap between neuroscience innovation and everyday wellbeing, powered by MEGIN's world-leading MEG technology.

👉 Don't forget to like, subscribe, and follow MEGIN for more conversations at the forefront of brain science.

MYndspan website: https://myndspan.com

MYndspan publications: https://myndspan.com/publications/

MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice. Consult your caregiver for medical advice.

TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Please contact MEGIN for further information. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

In this Spotlight, MEGIN host Zoë Etter sits down with Pediatric Epileptologist, Dr. Jeffrey Tenney, and Neurosurgeon Dr. Jesse Skoch from Cincinnati Children's Hospital. Together, they explore how MEG (magnetoencephalography) is transforming epilepsy care - from guiding surgical planning and enhancing diagnosis, to offering new possibilities for less invasive treatments. The clinicians share real patient cases where MEG made a difference, highlight the power of multidisciplinary collaboration, and discuss exciting research shaping the future of pediatric epilepsy treatment. 🔎 Learn how MEG is helping clinicians unlock the brain's complexity and aiming to provide better outcomes for children living with epilepsy. 🎧 Don't forget to like, share, and subscribe for more stories that inspire change.

MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Please contact MEGIN for further information.

Hosted by Nicole Sourry, Associate Director, Global Marketing and Sales at MEGIN.

Dr. Svetlana Pinet explains how MEG and AI are unlocking the mysteries of language production, and shares more about the groundbreaking Meta-BCBL research collaboration on mind-to-text communication.

Original Meta AI article: https://ai.meta.com/blog/brain-ai-research-human-communication/ Read the paper – Brain-to-text: https://ai.meta.com/research/publications/brain-to-text-decoding-a-non-invasive-approach-via-typing/ Read the paper – From thought to action: https://ai.meta.com/research/publications/from-thought-to-action-how-a-hierarchy-of-neural-dynamics-supports-language-production/

BCBL website: https://www.bcbl.eu/en

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice. *TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Please contact MEGIN for further information.

Hosted by Gabriele Richardson, Director, Global Sales and Marketing at MEGIN.

In this inspiring episode of the MEGIN Spotlights, we speak with Monika Jones, CEO and Co-Founder of the Pediatric Epilepsy Surgery Alliance - the only caregiver-led, science-driven nonprofit dedicated to enhancing the lives of children who need neurosurgery for medication-resistant epilepsy. Monika shares her personal journey as a mother of a child with epilepsy and how it led to the creation of this impactful organization. Learn how PESA empowers families through cutting-edge research, personalized support services, and critical education - before and after surgery. We explore how PESA is changing the narrative around epilepsy surgery, advocating for MEG technology, and driving global research collaborations through initiatives like the Global Pediatric Epilepsy Surgery Registry. Learn more about PESA: https://epilepsysurgeryalliance.org Global Pediatric Epilepsy Surgery Registry: https://epilepsysurgeryalliance.org/about/research/patient-registry/

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

As Medical and Scientific Directors of the hospital's MEG lab, our guests, Professor Debopam Samanta and Assistant Professor Diana Escalona-Vargas, discuss the role of MEG in pediatric epilepsy treatment, brain tumor mapping, and neuromodulation. They share groundbreaking fetal MEG research, discuss integration with ROSA One for precision surgery, and share how Arkansas Children's leverages MEG to advance patient care and solidify its position as a leader in pediatric neuroscience.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome MEG Director Dr. Abbas Babajani-Feremi and Neurosurgeon Dr. Maryam Rahman from University of Florida Health. They discussed using the TRIUX™ neo in their epilepsy and brain tumor treatment programs, and shared how they make the program financially sustainable through referrals, appropriate billing, and the use of MEGIN's internal helium recycling (IHR) technology. Additionally, our guests offered insights into emerging MEG research.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

In this Spotlight we welcome Theresa Williard, BSN, RN, CNRN, the MEG and TMS Manager at Le Bonheur Children's Hospital. Theresa discusses how to create a successful MEG program, and how to stand out from other healthcare providers. She also shares insights into the day-to-day responsibilities of her role and Le Bonheur's EMU program, including their sedation protocol.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome Elaine O'Loughlin, who we were introduced to at the Pediatric Epilepsy Surgery Alliance Conference in Boston. She was kind enough to share her daughter's experience of MEG as part of her epilepsy diagnosis and surgical planning at Boston Children's Hospital. We hear about her family's experience of being included in a MEG research study, how MEG data informed clinical decision making and surgical planning, and the positive changes this has had on her daughter's epilepsy and quality of life. Elaine also shares her advice for families who are facing similar challenges.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome our new strategic software partners FIND Neuro to the Spotlight. FIND Neuro will develop a multi-modal solution* to improve MEG utilization for pre-surgical evaluation.

On this Spotlight, we are joined by co-founders Noam Peled and Avi Yaron to discuss why FIND Neuro was created, learn more about our guests' backgrounds and share how MEGIN and FIND Neuro intend to work together.

You can learn more at https://findsurgicalsciences.com/

*FIND Neuro is a work in progress and not available for sale.

**MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.